Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Gilead's $1,000-a-pill hepatitis C drug may make financial sense for prisons

 

Gilead's $1,000-a-pill hepatitis C drug may make financial sense for prisons

2014-10-21 15:36:50| Biotech - Topix.net

Sovaldi's $1,000-a-pill price has grabbed headlines, but a new study suggests it may actually be cost effective for prison systems. Pricey new hepatitis C drugs, such as Gilead Sciences Inc.'s Sovaldi, may make financial sense to give to give to prisoners, one of the main groups infected with the liver-damaging virus, according to a team of Stanford University researchers.

Tags: make financial sense drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

26.06 Rockline Industries Wins WOW Innovation Award 26.06 IMS Technologies Expands Calcinate Production Site 26.06 Horizon expert 'gave evidence based on informal chats' 26.06 Automotive Color by BASF Recognized with Renowned Red Dot Award 26.06 Beckers Commits to Widespread Science Based Targets 26.06 PPG to Announce Second-quarter 2024 Results July 18 26.06 Fresh Coat for First Responders: New Hampshire Fire Station Gets a Makeover by California Paints 26.06 Michigan Sets Record Recycling Rate in 2023, Recycles Nearly 70,000 Tons of Materials More »